<DOC>
	<DOCNO>NCT01713283</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , antiviral activity sofosbuvir ( SOF ) ribavirin ( RBV ) Egyptian adult chronic genotype 4 hepatitis C virus ( HCV ) infection .</brief_summary>
	<brief_title>Sofosbuvir Plus Ribavirin Treatment-Naive Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus ( HCV ) Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>First generation Egyptian ; must bear Egypt trace maternal paternal Egyptian ancestry Treatmentexperienced treatmentnaive Chronic genotype 4 HCV infection Not coinfected HIV Screening laboratory value within define threshold Use highly effective contraception method Must able comply dose instruction study drug administration able complete study schedule assessment History clinically significant chronic liver disease Pregnant nursing female male pregnant female partner History clinicallysignificant illness major medical disorder may interfere treatment , assessment , compliance protocol Excessive alcohol ingestion significant drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>